Givaudan completes Ungerer buy
Givaudan, the world’s largest flavours and fragrances (F&F) house, today completed the acquisition of Ungerer & Company, which was originally announced in November 2019. Terms were not disclosed, but Givaudan said that the newly acquired business would have represented about $250 million of incremental sales in 2019 on a pro forma basis.
Ungerer was founded over 125 years ago and is based in New Jersey, making speciality F&F ingredients, most notably essential oils but also aroma chemicals. It was hitherto mainly owned by the Vorhees family. In all, it has eight manufacturing facilities and six R&D centres, employing 650 people. Givaudan CEO said that acquiring it “fits very well with our long-term strategy for our core business in F&F”.
RELATED ARTICLES
UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.
Swiss CDMO Siegfried has inaugurated its new global R&D centre for drug substances at its site in Evionnaz.
International Chemical Investors Group (ICIG), the owner of WeylChem and many other European chemical assets, has acquired the European Advanced Organics business of Valtris Specialty Chemicals.
SOCMA, the trade association of the US speciality chemical manufacturing industry, has published an open letter to the pending Trump administration, urging it to “prioritise policies that encourage advancement, streamline regulatory processes and incentivise domestic manufacturing”.
BASF has formed a partnership with Slovenian white biotech Acies Bio. Under this it will further develop the latter’s OneCarbonBio fermentation platform to derive methanol for the production of fatty alcohols for home and personal care ingredients, notably surfactants.
Peptides CDMO AmbioPharm, has broken ground on a 650 m2, $28 million expansion project at its Shanghai manufacturing site. This is due to be complete in 2H 2025 and will produce over 8 tonnes/year of crude peptide.
